Hetero-bivalent GLP-1/glibenclamide for targeting pancreatic β-cells. - Hart NJ; Chung WJ; Weber C; Ananthakrishnan K; Anderson M; Patek R; Zhang Z; Limesand SW; Vagner J; Lynch RM (Chembiochem : a European journal of chemical biology, 2014)